René Maltais

1.4k total citations
84 papers, 1.1k citations indexed

About

René Maltais is a scholar working on Molecular Biology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, René Maltais has authored 84 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 46 papers in Genetics and 31 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in René Maltais's work include Estrogen and related hormone effects (46 papers), Hormonal Regulation and Hypertension (27 papers) and Chemical Synthesis and Analysis (19 papers). René Maltais is often cited by papers focused on Estrogen and related hormone effects (46 papers), Hormonal Regulation and Hypertension (27 papers) and Chemical Synthesis and Analysis (19 papers). René Maltais collaborates with scholars based in Canada, Russia and Mexico. René Maltais's co-authors include Donald Poirier, Jenny Roy, Diana Ayán, Liviu C. Ciobanu, Van Luu‐The, Martin Perreault, Martin Tremblay, Xavier Barbeau, Patrick Lagüe and Sheng‐Xiang Lin and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

René Maltais

79 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
René Maltais Canada 20 599 561 349 316 117 84 1.1k
Martin Frotscher Germany 19 390 0.7× 722 1.3× 686 2.0× 359 1.1× 166 1.4× 46 1.2k
Jenny Roy Canada 17 333 0.6× 338 0.6× 181 0.5× 250 0.8× 108 0.9× 61 790
Surinder K. Chander United Kingdom 23 853 1.4× 933 1.7× 270 0.8× 325 1.0× 90 0.8× 38 1.7k
Joanna M. Day United Kingdom 18 449 0.7× 501 0.9× 309 0.9× 162 0.5× 101 0.9× 27 972
George F. Allan United States 22 957 1.6× 1.2k 2.1× 459 1.3× 431 1.4× 72 0.6× 46 2.0k
Yali He United States 18 535 0.9× 359 0.6× 508 1.5× 106 0.3× 62 0.5× 33 1.2k
Michael L. Mohler United States 19 419 0.7× 269 0.5× 416 1.2× 218 0.7× 50 0.4× 31 1.1k
Simon P. Newman United Kingdom 23 740 1.2× 647 1.2× 165 0.5× 391 1.2× 87 0.7× 32 1.4k
Tadas S. Vasaitis United States 19 525 0.9× 384 0.7× 307 0.9× 192 0.6× 159 1.4× 21 1.1k
Ross Weatherman United States 16 662 1.1× 640 1.1× 125 0.4× 338 1.1× 232 2.0× 25 1.3k

Countries citing papers authored by René Maltais

Since Specialization
Citations

This map shows the geographic impact of René Maltais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by René Maltais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites René Maltais more than expected).

Fields of papers citing papers by René Maltais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by René Maltais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by René Maltais. The network helps show where René Maltais may publish in the future.

Co-authorship network of co-authors of René Maltais

This figure shows the co-authorship network connecting the top 25 collaborators of René Maltais. A scholar is included among the top collaborators of René Maltais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with René Maltais. René Maltais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Fortin, Nicolas, Nathalie Goyette, René Maltais, et al.. (2024). A protectin DX (PDX) analog with in vitro activity against influenza A(H1N1) viruses. Journal of Medical Virology. 96(3). e29484–e29484. 1 indexed citations
4.
Maltais, René, et al.. (2024). Synthesis and characterization of targeted 17β-hydroxysteroid dehydrogenase type 7 inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. 242. 106544–106544. 1 indexed citations
5.
6.
7.
Maltais, René, et al.. (2020). Synthesis of 17β-hydroxysteroid dehydrogenase type 10 steroidal inhibitors: Selectivity, metabolic stability and enhanced potency. European Journal of Medicinal Chemistry. 209. 112909–112909. 12 indexed citations
8.
Roy, Jenny, et al.. (2020). Insight into the Mechanism of 17β-Hydroxysteroid Dehydrogenase Type 3 Inhibition by the Androsterone Derivative RM-532-105. Current Enzyme Inhibition. 16(3). 243–250. 3 indexed citations
9.
Maltais, René, Martin Perreault, Jenny Roy, & Donald Poirier. (2019). Minor chemical modifications of the aminosteroid derivative RM-581 lead to major impact on its anticancer activity, metabolic stability and aqueous solubility. European Journal of Medicinal Chemistry. 188. 111990–111990. 7 indexed citations
10.
Li, Tang, René Maltais, Donald Poirier, & Sheng‐Xiang Lin. (2018). Combined Biophysical Chemistry Reveals a New Covalent Inhibitor with a Low-Reactivity Alkyl Halide. The Journal of Physical Chemistry Letters. 9(18). 5275–5280. 19 indexed citations
11.
Roy, Jenny, et al.. (2018). Identification of steroidal derivatives inhibiting the transformations of allopregnanolone and estradiol by 17β-hydroxysteroid dehydrogenase type 10. Bioorganic & Medicinal Chemistry Letters. 28(22). 3554–3559. 12 indexed citations
12.
Maltais, René, et al.. (2015). Identification of fused 16β,17β-oxazinone-estradiol derivatives as a new family of non-estrogenic 17β-hydroxysteroid dehydrogenase type 1 inhibitors. European Journal of Medicinal Chemistry. 93. 470–480. 12 indexed citations
13.
Ayán, Diana, et al.. (2015). The Aminosteroid Derivative RM-133 Shows In Vitro and In Vivo Antitumor Activity in Human Ovarian and Pancreatic Cancers. PLoS ONE. 10(12). e0144890–e0144890. 17 indexed citations
14.
15.
Ayán, Diana, René Maltais, Jenny Roy, & Donald Poirier. (2012). A New Nonestrogenic Steroidal Inhibitor of 17β-Hydroxysteroid Dehydrogenase Type I Blocks the Estrogen-Dependent Breast Cancer Tumor Growth Induced by Estrone. Molecular Cancer Therapeutics. 11(10). 2096–2104. 40 indexed citations
16.
Ajeawung, Norbert Fonya, René Maltais, Chris Jones, Donald Poirier, & Deepak Kamnasaran. (2012). Viability screen on pediatric low grade glioma cell lines unveils a novel anti-cancer drug of the steroid biosynthesis inhibitor family. Cancer Letters. 330(1). 96–105. 12 indexed citations
17.
18.
Maltais, René & Donald Poirier. (2011). Steroid sulfatase inhibitors: A review covering the promising 2000–2010 decade. Steroids. 76(10-11). 929–948. 56 indexed citations
19.
20.
Poirier, Donald & René Maltais. (2005). Solid-Phase Organic Synthesis (SPOS) of Modulators of Estrogenic and Androgenic Action. Mini-Reviews in Medicinal Chemistry. 6(1). 37–52. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Frotscher Breakdown of academic impact, for papers by Jenny Roy Breakdown of academic impact, for papers by Surinder K. Chander Breakdown of academic impact, for papers by Joanna M. Day Breakdown of academic impact, for papers by George F. Allan Breakdown of academic impact, for papers by Yali He Breakdown of academic impact, for papers by Michael L. Mohler Breakdown of academic impact, for papers by Simon P. Newman Breakdown of academic impact, for papers by Tadas S. Vasaitis Breakdown of academic impact, for papers by Ross Weatherman
Rankless by CCL
2026